Nanobiotix SA (XPAR:NANO) Stock News, Headlines & Updates
Nanobiotix SA Stock News from GuruFocus
- 1
Jun 12, 2024
NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
Marketwired • 4:00pm
Jun 11, 2024
Voting Rights and Shares Capital of the Company
Marketwired • 4:00pm
May 28, 2024
NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
Marketwired • 4:00pm
May 23, 2024
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
Marketwired • 4:00pm
Q1 2024 Nanobiotix SA Earnings Call Transcript
GuruFocus Research • 4:04am
May 22, 2024
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
Marketwired • 1:00am
May 21, 2024
Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
Marketwired • 4:00pm
May 16, 2024
Voting Rights and Shares Capital of the Company
Marketwired • 4:00pm
May 15, 2024
NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
Marketwired • 4:00pm
May 14, 2024
NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
Marketwired • 4:00pm
Apr 24, 2024
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Marketwired • 4:00pm
Apr 17, 2024
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
Marketwired • 4:00pm
Apr 10, 2024
Voting Rights and Shares Capital of the Company
Marketwired • 4:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news